The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update.
CONCLUSIONS: Naltrexone/bupropion combination appears to be an effective adjunct to a comprehensive lifestyle intervention in order to achieve weight loss and treat obesity-related comorbidities.
PMID: 26188223 [PubMed - as supplied by publisher]
Source: Hormones - Category: Endocrinology Tags: Hormones (Athens) Source Type: research
More News: Bupropion | Cardiology | Cholesterol | Constipation | Depression | Eating Disorders & Weight Management | Endocrinology | European Medicines Agency (EMA) | Headache | Heart | Hormones | Insulin | Migraine | Obesity | Suicide | Weight Loss | Wellbutrin